Skip to main content
Premium Trial:

Request an Annual Quote

Tennessee's COVID-19 Sequencing

A state lab in Tennessee has added the ability to run its own genome sequencing analyses of SARS-CoV-2 samples, the Tennessean reports.

Previously, it says, SARS-CoV-2 sequencing in the state was limited to university and private labs. But beginning in July, a state lab has implemented its own sequencing tools and can currently process 75 to 90 SARS-CoV-2 samples per week, with plans to ramp that number up into the hundreds, the Tennessean adds.

It notes that the ability to sequence SARS-CoV-2 samples is giving Tennessee a better idea of which variants are circulating in the state. "By doing more sequencing, we're better able to look at those variants emerging in almost real time," Kara Levinson, the deputy director of the lab, tells the Tennessean. "So, it's certainly key to being able to kind of predict where this virus might be heading."

Tennessee, the paper adds, is reporting an average 7,400 new COVID-19 cases per day, down from an average 9,450 new cases per day a few days ago.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.